China Financial Results 16/11/13 – China Mobile Games & Entertainment, Tianyin Pharmaceutical, Skystar Bio-Pharmaceutical, China Pharma

China Mobile Games & Entertainment Reports Third Quarter 2013 Unaudited Financial Results

  • Revenues were RMB98.1 million (US$16.0 million), 125.0% and 36.3%  increases compared with RMB43.6 million in the third quarter of 2012, and RMB72.0 million in the second quarter of 2013, respectively. The  sequential quarterly growth in revenue is largely due to the increased revenue in social games and the expansion of the Company’s third-party  game publishing business.
  • Net income was RMB25.6 million (US$4.2 million) for the third quarter of  2013, compared with net income of RMB1.6 million in the third quarter of  2012 and net loss of RMB12.6 million in the second quarter of 2013.
  • Non-GAAP net income, which excludes share-based compensation expenses,  was RMB24.9 million (US$4.1 million) in the third quarter of 2013,  compared with non-GAAP net income of RMB6.7 million in the third quarter  of 2012 and non-GAAP net loss of RMB3.9 million in the second quarter of  2013.
  • Basic and diluted earnings per American Depositary Share (“ADS”) in the  third quarter of 2013 were RMB0.98 (US$0.16), compared with basic and  diluted earnings per ADS of RMB0.04 in the third quarter of 2012 and basic  and diluted loss per ADS of RMB0.66 in the second quarter of 2013.

Tianyin Pharmaceutical Reports First Quarter Fiscal Year 2014 Financial Results

  • Revenue was $14.8 million compared with $16.0 million in the first quarter  fiscal year 2013, a decrease of 8.1% year over year
  • Operating income was $2.2 million, compared with $2.1 million in the first  quarter fiscal year 2013, an increase of 1.4% year over year
  • Net Income was $1.5 million compared with $1.5 million in the first  quarter fiscal year 2013
  • Earnings per share of $0.05 per basic share, $0.05 per diluted share,  compared with $0.05 per basic share, or $0.05 per diluted share in the  first quarter fiscal year 2013
  • Cash and cash equivalents totaled $25.6 million on September 30, 2013

Skystar Bio-Pharmaceutical Reports Third Quarter 2013 Results

  • Revenues increase 79% YoY to $16.0 million
  • Gross margin of 51.4% for the third quarter of fiscal 2013 as compared to 58.9% in the year ago period
  • Net income of $3.7 million or $0.49 per fully diluted share, compared with net income of $2.7 million or $0.36 per fully diluted share in  the year ago period
  • Fiscal 2013 guidance reiterated at $40 million to $45 million

China Pharma Holdings, Inc. Reports Third Quarter 2013 Financial Results

  • Revenue decreased 33% to $8.1 million in the third quarter of 2013 from  $12.2 million in the third quarter of 2012.
  • Gross profit was $2.2 million in the third quarter of 2013, a decrease of  approximately $1.0 million compared to $3.2 million gross profit in the  third quarter of 2012.
  • Net loss was $2.3 million in the third quarter of 2013 compared to $1.3 million net income in the third quarter of 2012, a decrease of $3.6  million. Earnings (loss) per common share was ($0.05) per basic and  diluted share in the third quarter of 2013 compared with $0.03 per share  in the same period last year.
  • Candesartan, a front-line drug therapy for the treatment of hypertension,  was launched in November, 2013 and we expect this product to generate  revenue in the fourth quarter of 2013.
  • Our “National High-Tech Enterprise” status (“National HT Status”) was  successfully renewed in the third quarter of 2013. With this designation,  we continue to be entitled to a preferential tax rate of 15% for the years  ending December 31, 2014, 2015 and 2016, which is notably lower than the  statutory income tax rate of 25%.
Advertisements

One comment

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s